USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
European Non-invasive Prenatal Testing Market, Forecast to 2028
European Non-invasive Prenatal Testing Market, Forecast to 2028
Driving Progress in Screening Techniques Amplifies Accessibility and Adoption of NIPT, Cultivating a Broader Patient Engagement in Europe
19-Jan-2024
Europe
Description
The European non-invasive prenatal testing (NIPT) market will experience significant growth thanks to technological advancement, increasing awareness among expectant parents, and the rising incidence of chromosomal abnormalities in fetuses. The market has experienced a surge in demand due to its products’ non-invasive nature compared to traditional invasive prenatal testing methods like amniocentesis or chorionic villus sampling (CVS).
In recent years, the European NIPT market has displayed a notable trend toward personalized medicine. Technological innovations have led to the development of advanced NIPT tests that offer higher accuracy in detecting chromosomal abnormalities, such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). Additionally, the growing preference for early and non-invasive prenatal screening has significantly contributed to the market's expansion.
The intense competition within the NIPT industry in Europe is fueled by advancements in technology—bioinformatics, artificial intelligence, next-generation sequencing (NGS)—and the growing need for precise prenatal diagnostics. Additionally, the competitive environment becomes harsher due to broad market penetration, operational efficacy, and innovation. Rising startups are changing the industry by bringing innovative technology like exclusive platforms and AI-powered analytics to meet certain unmet demands. NIPD Genetics and other notable firms are at the forefront of innovation in the field, pioneering innovative testing.
Table of Contents
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on Europe’s NIPT Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Summary
Summary (continued)
Scope of the Study
NIPT European Country Segmentation
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Forecast Analysis
Revenue Forecast by Country
Forecast Analysis by Country
Forecast Analysis by Country (continued)
Forecast Analysis by Country (continued)
Forecast Analysis by Country (continued)
Forecast Analysis by Country (continued)
Forecast Analysis by Country (continued)
Regulatory Landscape for Europe’s NIPT Market
Europe’s NIPT Reimbursement Pathways
Reimbursement Scenario—European Union 5 (EU5)
Reimbursement Scenario—European Union 5 (EU5) (continued)
NIPT Test Pricing Analysis by Country—2023
Competitive Environment
Key Competitors
Europe’s NIPT Market Competitive Landscape
Europe’s NIPT Market Competitive Landscape by Player
Competitive Mapping by NIPT Offering Parameters
Competitive Mapping by NIPT Offering Parameters (continued)
Comparison with the US Market
Europe’s NIPT Market—Notable Activities
Competitors—NIPT Business Reviews and Milestones
Companies to Watch—BGI Bioscience
Companies to Watch—Illumina
Companies to Watch—PerkinElmer
Companies to Watch—Roche Diagnostics
Companies to Watch—Eurofins LifeCodexx GmbH
Companies to Watch—Yourgene Health Plc (Novacyt)
Companies to Watch—Cradle Genomics
Companies to Watch—Natera, Inc.
Companies to Watch—Quest Diagnostics
Companies to Watch—NIPD Genetics
Companies to Watch—Progenity (Biora Therapeutics, Inc.)
Companies to Watch—Everly Health
Companies to Watch—Labcorp
Industry Mega Trends
Growth Opportunity Summary
Growth Opportunity 1: eCommerce and DTC Sales
Growth Opportunity 1: eCommerce and DTC Sales (continued)
Growth Opportunity 2: Partnerships and Joint Ventures with Local Labs in Europe
Growth Opportunity 2: Partnerships and Joint Ventures with Local Labs in Europe (continued)
Growth Opportunity 3: Low-Cost Solutions Leading to Cost-efficiency and Accessibility for Market Expansion
Growth Opportunity 3: Low-Cost Solutions Leading to Cost-efficiency and Accessibility for Market Expansion (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
Popular Topics
| Author | Chandni Hussain |
|---|---|
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Prenatal Testing Trends |
| Keyword 2 | Non-Invasive Testing Industry Insights |
| Keyword 3 | Healthcare Technology Trends |
| Podcast | No |
| WIP Number | MH32-01-00-00-00 |